N. Nisaurrahmah, O. Sri, and I. Ifora, “Efficacy and Safety of 5-Hydroxytryptamine-3 Receptor Antagonists (5-HT3 RAs) for The Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Review”, J. Drug Delivery Ther., vol. 11, no. 1-s, pp. 195–199, Feb. 2021, doi: 10.22270/jddt.v11i1-s.4554.